Non-lamellar lyotropic liquid crystalline nanoparticles as nanocarriers for enhanced drug encapsulation of atorvastatin calcium and proanthocyanidins
Atorvastatin calcium (ATV) and proanthocyanidins (PAC) have a strong antioxidant activity, that can benefit to reduce the atherosclerotic plaque progression. Unfortunately, the bioavailability of ATV is greatly reduced due to its limited drug solubility while the PAC drug is unstable upon exposure t...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | Maslizan, Mardhiah, Haris, Muhammad Salahuddin, Ajat, Mokrish, Md Jamil, Siti Nurul Ain, Azhar, Shah Christirani, Zahid, N. Idayu, Mat Azmi, Intan Diana |
|---|---|
| Μορφή: | Άρθρο |
| Έκδοση: |
Elsevier BV
2024
|
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|
Παρόμοια τεκμήρια
-
Formulation and characterization of anti-atherosclerosis drug loaded liquid crystalline nanoparticle
ανά: Maslizan, Mardhiah
Έκδοση: (2022) -
Formulation and characterization of anti-atherosclerosis drug loaded liquid crystalline nanoparticle
ανά: Maslizan, Mardhiah
Έκδοση: (2022) -
Formulation and characterization of anti-atherosclerosis drug loaded liquid crystalline nanoparticle /
ανά: Mardhiah Maslizan, -
Enzyme nanocarriers /
Έκδοση: (2015) -
Nanocarrier Technologies Frontiers of Nanotherapy /
Έκδοση: (2006)
